Details of the Drug

General Information of Drug (ID: DMD9LWN)

Drug Name

Donidalorsen

Indication

Disease Entry	ICD 11	Status	REF
Hereditary angioedema	4A00.14	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Ligand-conjugated antisense

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Plasma kallikrein messenger RNA (KLKB1 mRNA)	TTN0PCX	KLKB1_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05392114) An Open-Label, Long Term Safety and Efficacy Study of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE). U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Ionis